Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
DeSci Rising x SpectruthDAO | ep 6
Recorded: April 16, 2025 Duration: 1:22:12Space Recording
Short Summary
The Desai Rising Series kicks off its second season, spotlighting SpecTruthDAO, a pioneering project aimed at revolutionizing PTSD care through AI and decentralized governance. With a focus on innovative treatments and community involvement, this initiative represents a significant trend in the crypto space towards addressing mental health challenges.
Full Transcription
Thank you. Good morning.
Hey, James.
How are you doing?
I'm doing great.
How do I pronounce your name correctly?
Jelani.
Jelani.
Great to meet you.
Nice to meet you as well, man.
So your audio sounds great.
So for context, I open up the space just a little bit earlier than the scheduled time
just to let you come in or let the guest speaker kind of just come in, situate if there's
any hiccups, if it's their first time, you you sound good um so i'll usually roll this out is about close to
you know a couple minutes after we kind of kick it off we have a little bit of an intro that i
give for the series and then we jump right into to learning about you man and what you guys do
and what the whole goal is and kind of unfolds into a nice
discussion awesome um should i just do like a five minute about myself 10 minute what is the ideal
because i don't want to go too long but don't want to be too brief either you have an hour for
yourself so however like you know my normal questions first couple questions are are about
you and about the team but more so around, what was your journey to Web3?
What was your journey to DSi?
So that's as we want the truth, right?
So whatever, however much time it takes, and I might jump in here with questions, but it really is like a discourse, right?
Like I'm looking to get to know you and through that, the rest of the community will also get to know you.
Sounds awesome.
Perfect. Perfect.
Yeah.
So we'll kick it off in a little bit.
So just hang tight, take it easy, wait for a few people to more,
prove more people to trickle in.
But for context afterwards, we also put up a lot of like post spaces,
content, like little video clips and videos that you can use to also share
with the rest of the community.
And people usually listen to this back after the fact. that's it so just hang tight um i'll kick it
off in a couple minutes and then we'll go we'll do cool Thank you. Thank you. all right gents we'll kick it off and people will trickle in over time.
So, hello everybody.
My name is Jelani and welcome to Season 2, Episode 6 of the Desai Rising Series, where
our goal here is always to kind of highlight the many wonderful projects on our growing
Desai World dashboard and just give them the opportunities, just formally introduce themselves,
update their progress, highlight their achievements, and just generally engage with both the dsai world
and the wider dsai community now the idea behind all this is always that at dsai world we very much
believe that more than the tech more than the funding it is the community using these tools
that will usher in many of the changes that we're all hoping for DSi to bring to the various legacy STEM industries. Now, I say this at the beginning of every episode, and it holds true for every
episode, but in today's episode, we have a very special guest. And I think that this is the first
spaces that we've had at DSiWorld for sure, but also across the wider D-Sci space that is not committed to, it's committed
to a mental health types infrastructure, right?
A mental health type application of D-Sci.
And I think that's fantastic because it speaks to ideally the growth of D-Sci
into slightly different verticals than what we've classically seen.
So without further ado, I'd like to introduce James Holtz, who was the
founder of SpecTruthDAO, which is a community
seeking to revolutionize PTSD care with AI, DSI, and community-driven governance, with the goal to
hopefully deliver personalized diagnostics, therapy, and advanced treatment to patients.
Now, with all that being said, James, I'd like to first thank you very much for taking the time to
out of what I'm sure is a busy day to meet with me, to come and talk about Spectru Thao, and to just have us learn about some of the cool stuff that you guys are doing.
Thank you for having me. It's an absolute pleasure. This will be our first, I guess, AMA.
Time-wise, it's absolutely perfect. It's 7 o'clock here in Kiev, so days already winded down.
All the employees have already left, and now it's just talking a little bit about the project. It's seven o'clock here in Kiev. So days already winded down.
All the employees have already left.
And now it's just talking a little bit about the project.
That's amazing.
And I love it because in your banner, in your official account banner, it says incubated or started in the US, but also now existing in Ukraine.
And I love the cross divide because there is a nuance to mental health. There's a nuance to mental health treatment that factors in culture that factors in so many extra social determinants that are inherently different in different locations. And so I imagine that that kind of filters its way through in a command in a community of individuals that are looking to tackle mental health in its various forms. You guys specifically say PTSD, but then that in and of itself is a broad spectrum.
And so I'd love to kind of dive into some of that, of the infrastructure.
But as I mentioned to you at the beginning, the idea here is to really emphasize who the
founders, who the creators are for people who are interested in participating.
So for yourself, I'd love to hear what was your
journey from where you were at previously that led all the way up to the development of Spectrum
Thao? Oh, definitely. I'd love to talk about it. And I'll actually answer your question
very quickly on the other observation. And we did start in the United States.
in the United States. My trade by profession is I'm a lawyer in the state of Florida. And
as a side project, I created three autism schools and five autism clinics that would help children
receive therapy. That's a hell of a side project. Okay. It's definitely a side project.
Did very well in it. It was very successful.
The goal was basically to provide therapy for free.
And we addressed it using insurance differently.
As a lawyer, I saw a lot of creative ways that we could actually build insurance companies with certain projects, basically TRICARE for the veterans.
basically TRICARE for the veterans. And then it basically created enough revenue that we could
do about a 50% increase in the salary of our employees and provide almost a free education,
free therapy for most of our clients. During COVID, I exited that project and I actually
retired from law and I went on a one-year walkabout. And it took me all around the world.
law and I went on a one-year walkabout and that took me all around the world.
Vienna, Italy, Sweden.
I eventually wound up in Ukraine and I stayed there for a while until I met my wife.
We got married and that's a whole nother story for another day.
It's a whole other story for another day.
And it's been absolutely great.
And it's been absolutely great.
But what led me to being in Ukraine from the business side of it was as I created Spectrate because I wanted to do PTSD and work with veterans in the United States.
I grew up on military bases.
My father was a chaplain in the Army.
And he became a chaplain using his GI bill when he volunteered to go to Vietnam for
three years in a row. So where most people are being drafted, he volunteered and then he reenlisted
and reenlisted. And he's one of those people that when you watch a TV show, he is the quintessential Vietnam vet with chronic PTSD. But he does have a doctor's degree.
He used his GI Bill to go to university, get his seminary degree. And super smart,
super educated. He is self-aware. He understands what he's doing, and he also knows that he suffers probably about 100%
disability relating to PTSD. And growing up and seeing that, seeing the effect of it on my mom,
myself, himself, you know, I mean, he is self-aware when he's doing self-destructive
behavior, but it's a compulsion. It's not like there's a choice
or anything along those lines. And it's just always been in the back of my mind.
So when I came to Ukraine, you know, 30, 40 years fast forward, although I'm in a safe part of
Ukraine, there's over a million veterans who have come back from the
zero line already. And we're talking about a vast majority are experiencing PTSD. And
one thing we have to talk about on PTSD is you're absolutely right. There is a huge spectrum between
a person who has a bad dream and then another person who cannot hold a job.
And it reminds me of the old videos on YouTube short or Instagram where the World War I where
people had shell shock, where their whole bodies were shaking or uncontrollable laughter,
people who couldn't sleep for six days straight. I'm seeing that here firsthand.
And it is horrific. It's horrific anywhere in the world. You know, I know in the Sudan,
there's issues. Yemen, there's issues. Gaza, Israel. I mean, it's not an isolated thing as
to people say, well, why are you focusing on one person or one group?
I just happened to be in Ukraine when it happened. And I transitioned all my efforts here in two parts.
One, a desire to have an outcome so other children don't have to grow up the way I did.
Two, there's not the red tape
in Ukraine that there is in the United States. There's some amazing therapies that people are
doing. Xenon therapy in Russia. In Mexico, people are using Ibogaine. In South America, you can
freely use psilocybin.
I even know that there's some countries in Europe like King's College that are doing some tests with psilocybin.
And you just can't in the United States.
The red tape is just horrifically cumbersome.
And it's because the United States treats almost every ailment in a pill form.
It's a pharmaceutical goldmine.
And why cure what you can treat for 30 years?
So knowing that, I basically have dived very deep for my own sake, for my own knowledge, and then applying it into this business.
So I'm taking my experience as a lawyer, I'm taking my experience of successfully creating,
operating, exiting autism schools. And what I'm trying to create here is a PTSD clinic
that does research and development, focuses on repurposing existing
compounds that we know work for other things, but have not been approved for PTSD and addiction.
Try new medicines, which would be like ibogaine psilocybin. And then I also want to create a second part, which is behavioral. And in the
behavioral side, the goal is to use AI agentic agents. You know, when you have 1.4 million people
in one country coming back from the zero line, vast majority of them have PTSD.
You're talking about tens of thousands of therapists
that would be needed to help these people. And it's just not feasible, manpower-wise,
to produce that many therapists. What we've learned, and when you read the Yale journals,
and when you read a lot of peer-reviewed literature, you find out that about 84 to 86% of people with PTSD on the
behavioral side can be treated with cognitive behavioral therapy. And CBT can be recreated
with human-like qualities and characters and consistency with using AI agents.
consistency with using AI agents.
So our focus is really think of it as a funnel.
And the funnel is using AI agent that does the diagnostic testing.
That'll free up personnel to focus on other things.
Once the person is identified, what I want to do is work with either
another DAO or D-Side project. I actually spoke
with a gentleman today out of Dubai where they do biomarkers. Take the biomarkers of every person.
That way we can track the progress through the therapy. Have the cognitive behavioral therapy
administered because we know it's going to be helping a vast majority of people,
knowing that that last 14 to 15 percent is not being helped.
That group will then go to a physical clinic here in Kiev where we'll be able to, again,
identify the biomarkers and see which will benefit most given the different criterias. There is a group
out of America and the United Kingdom that is called Save the Warrior. I met a person today,
ironically, so this is great timing for the AMA. And he talked about how there's basically a decompression system.
And what they're doing is they're looking at it as a holistic, even spiritual sense
of somebody comes in, it's about 72 hours, and they do blood work, they help them with meditation they calm them down they're trying to basically almost
detox them and then they start going in through the therapies so I think what they're doing is
absolutely amazing and rather than recreating the wheel basically take something very similar to that, bring it here, and then basically just add a lot more
science to it. Because places like America, Canada, United Kingdom, Europe, they need science,
peer-reviewed journal articles to allow changes in policy. And right now, the policies aren't
allowing Ibogaine or psilocybin or those treatments,
even TMS where people are using magnetic pulses
to the brains, which are very interesting.
Xenon gas, extremely interesting.
Stella blockers going through the vagus nerve,
it's showing stream, I would say in the high 90s on the cure rate for chronic PTSD.
And the reason it's important that we're focusing here is by focusing on the soldiers here with the
least red tape where we have a government that wants us to actually find solutions that are cost effective and remedial done one procedure
and it's over versus 30 years of pharmacology.
It's an amazing opportunity to see if we can move this science forward.
I mean, ever since wars began, you know, between Cain and Abel until now, people have experienced
gaining ABLE until now. People have experienced this. It's astronomical what could be done
this.
if we can find the cures. And with the modern big data, it's very possible that we could
find a linchpin cure to most people. My goal at the end of the day is a first responder from a police, a veteran,
a housewife who went through 10 years of domestic violence could go in and see a doctor. They take
her blood and the biomarkers tell them which one she would respond to or him. I would love it where
a doctor could go in and the AI says the patient A needs xenon therapy.
Patient B needs Ibogaine.
Patient C, you know, just needs cognitive behavioral therapy and then have it scientifically proven with solutions.
So that's our goal.
What we're doing in Spectruth is three parts. One is the behavioral where we're working
with an AI developer now who's going to be doing the machine learning agentic.
We're going to be using future tokens as
a reward system for behavioralists and psychologists to upload their treatment planning.
So a doctor out there who has, you know, 3,000 treatment plans where they have assisted people
with PTSD, they can upload the treatment protocols, the answers, the dialogues, the
user outcomes, and they'll receive a token. they benefit from it long term while that's also
building our database for machine learning to basically develop its agentic AI.
The second part is we're going to be doing biomarkers and then wearables. I know there's a few DAOs who are using like the Cure Ring with Axon.
I want to say Aleda has a wearable.
We're going to try and make it where a multi-platform AI will work with whatever wearable somebody wants.
will work with whatever wearable somebody wants.
So if a person is in Canada and they have access
to a curing, we would love to be able to set it up
and have our AI not only monitor their vitals,
but act as an early warning system.
So if there's any triggers, it will actually go to the phone
and get them through the self-meditation therapies
to calm down and seek outside help if it's
absolutely necessary. The whole time, do the biomarkers through progress, even six months
after, one year after, so we can see if it's long-term, short-term. Also find out, we saw that there was a recent study where it showed that PTSD
has passed down for three generations, but it was done on a very small group. We want to do it on
a thousands group. We want everything to be indisputable with large scale big data. And
then of course the third element is doing the new novel treatments
and just keep an open mind as to what's out there. Asia, Russia, America, EU, they all treat it
differently. And we want to find out which one's the best, which one is scientifically recreatable.
That is a very holistic sort of in a nutshell i mean in a nutshell
is definitely an underrated way of defining it i think it really is it always impresses me
especially in this season of desai how sophisticated how much more sophisticated
projects have become um and it could be know, not just the project infrastructure, but actually the scope
and the builders behind these projects that understand more so than just, you know, this
is a web three solution, but this is a rep three solution interwoven with existing infrastructure
interwoven with a number of different policies to actually make these things pragmatically
possible.
And everything that you've described just seems very well thought out and
planned in a way that is executable.
And it's more, you know, a series of whether it requires funding or whether
it requires time or whether it requires manpower, this is not an if, but a when.
And I think that as a baseline is an ex is a fantastic example of what i hope to be the
maturity coming out of the space with people who are professionals and i use the term professionals
very loosely um in how they are approaching this so i mean that sounds fantastic so many questions questions that I have. I absolutely like the desai as a concept. But I feel like crypto as a whole
is struggling with finding its identity. Desai is included into that. You know, when I first
saw bio, bio protocol, I was absolutely like, that's it. You know, it's, it's about time we got away
from, um, uh, what is that pump, pump dot fun, pump dot, uh, shit. Yeah. What was it? I just,
the, the mean generator, the mean generator is just destroyed the utility aspect of it because
it turned it into a casino. And I really liked it.
That direction Molecule was going.
I liked the direction Bio was going in.
They've had recent launches, like I think Spined Out,
which I really think is just a great concept,
that you have genuine physicians,
that that's their specialty,
where they want to raise the money to do life-changing procedures.
I love that stuff. What I don't like in the DSI is where people make claims to do research that
are just not feasible on its face. Yes. You know, I like PsyDOW that they want to do psilocybin,
but then when you do the research, you're like, okay, well, they're in a country that it's legal.
So I'm 100 percent for CIDAO.
I wish them the best. I want them to do well.
If I can get permission to do psilocybin in Ukraine, I'd love to do a collaboration with a legal company that is working in that field.
a legal company that is working in that field.
What I don't like in the DSI is where these other people
have jumped on the bandwagon, like,
hey, we're gonna do psilocybin in Oregon,
or we're gonna do psilocybin in Colorado.
And you're just like, it's a federal schedule one drug.
You will go to jail for 40 years
if you do what you say you're going to do.
You know, like, why are you announcing
you're gonna be doing a schedule one
related crime in your research it's just mind-boggling yeah and this is where you know
this is where what i mean in terms of the maturity right so certainly you always have people who are
i guess a little bit less they don't have the same they don't have them put it in as much thought
they have an idea and they want to run with it.
Um, but that will run them into the ground.
Right.
And to a certain extent you want, you need those people because they, they are the effectively
the dreamers, they kind of lay out the potential landscape or the potential paths that one could
take if you approach it a specific way.
But, but specifically to decide, like the idea here being there's that impact is,
is first and foremost, everything else is a tool with which to achieve said impact,
whether it be web two or web three or whatever, have you combination that you want to do.
Um, it's impact driven.
And so to your point, like you need to understand the landscape with which you're operating in,
right.
With the playing field that, that you want to, with the game that you want to play.
So, I mean, again, it sounds like you have a good understanding of it.
I love the interoperability concept that you have up the front.
The idea of collaborating across other institutions, other entities,
but also different technology stacks.
For something that is so multimodal, it would be,
it just makes sense to have multimodal approaches to it. Right. And that's just talking about
PTSD, but any of the other number of psychological, um, states that require treatments,
you know, it's unlikely to be one thing and one bullet for each of these things,
right? Oh, I agree. And I think it's just also cross-disciplinary also. It's not just mental
health. I mean, if you take mine just because it's easier, I'm in it so I can see it.
For me to become an expert in wearables doesn't make sense. For me to become an expert in AI agentic, why?
There's truly gifted people out there that are light years ahead of my experience level.
So let them shine.
Wearables, I have not seen the Axon cure ring yet.
I heard good things about out of Desai London that I had a friend that saw it and loved
it. Why would I recreate something that somebody else has successfully already created? You know,
my goal is outcome. And I'm not threatened by anybody. Like there's a later, I'm not threatened
by them on any level. I want them to be successful because the way I look at it is even if I just stay in Ukraine, I have 1.4 million veterans that I can treat.
My clinic right now is going to be set up where I can help eight people at a time.
I can help eight people at a time.
You can do three cycles in a week because it's basically 48-hour increments, taking Sunday off.
It's impossible.
The pool that I'm working with is almost so vast that I need competitors to have a positive outcome.
I mean, I can be here a hundred years
and still not scratch the surface.
Absolutely.
And I think that really is the different approach
or hopefully the different approach
where it's exactly that.
Like there's enough for everybody.
And as a matter of fact,
we become better than the sum of our individual parts
by working together.
And I think that's ideally the paradigm
where we're moving towards,
right? Especially in a realm that is prophylactic or is not necessarily reactionary towards a
disease, but is trying to be preventative. That is such a conundrum space. There's so many
different variables that come into play here that you need to just have a solid team.
And teamwork really, in this case, teamwork really makes the dream work, right?
To your point of multidisciplinary.
But even multidisciplinary, not just from the scientific landscape, but from an actual business entity landscape.
I think the world is shifting towards these multifaceted, almost organismal approaches to things.
Definitely. And it's great. multifaceted, almost organismal approaches to things.
Definitely. And it's great.
It's great.
And then we also have to be more, I guess, loose
in probably a horrible way to describe it.
But when you see supply chain management
because of tariff wars, it's eye opening in the sense that we need to learn
how to be self-reliant and work with other teams
that are self-reliant so there really is no disruptions.
Absolutely.
And so let's dig into it.
So speak to me about Spectru's structure infrastructure.
So you mentioned that you have, I think,
three major modalities or
three major initiative areas. What are the actual components of the quote-unquote entity? Are you
incorporated entity? Do you have a community of individuals? What makes up Spectruth though?
Well, it's early enough on that it's just me at the moment. I created it in Wyoming as an LLC
because it has the best tax laws in the
United States. And I did it as a result of, this is before Trump made it official, but the rumors
were that he wasn't going to have tokens, capital gains tax on token sales. So I preemptively
went to Wyoming, opened it up as a simple LLC. From a real standpoint, I'm trying to create it
as a DAO. I want it as a decentralized autonomous organization where people can vote on the
treatment protocols and also benefit from the IP on the NFTs. It's a little bit on the legal
side of it. It's simple, but yet it's hard.
When you read everything online on Google and you read the Twitter comments,
it's clearly written by people who never read a law book,
let alone law school.
You know, the DAOs have to be set up
as a limited liability partnerships for people, whether you have one share or 10 shares, has a vote.
There has to be a governance protocol.
There has to be regular votes on not just broad things.
Like I saw Joop's DAO, where, you know, vote on three things on how much money they get paid.
That is not a decentralized autonomous organization by any means.
A Dow for our benefit is going to be we have a budget of $200,000.
It will cost $140,000 to do an Ibogaine study.
an Ibogaine study, this is the benefit, this is the downside.
This is the benefit.
This is the downside.
Here's another study, and you give people like six or seven choices on what a professional
team is recommending on the budget.
You can have two or three, but the more you have, the better.
And then you put them to the governance test.
So if you have 100,000 votes out there and you put the website out there,
you make it very clear, you know, here's an Ibogaine study, here's a psilocybin study.
We're not going to buy, we're not going to do any studies. We're going to buy 1,000 watches and give
it to soldiers on a frontline so we can test their biomarkers before they become veterans and enter
the system where they actually need to receive it and see what percentages of frontline actually do get PTSD.
I mean, there are so many avenues that we could explore that if we could identify the biomarkers.
Imagine, for instance, the United States when they're not drafting now,
but let's just say 10,000 people sign up for the Marine Corps.
Can you imagine if during the recruitment process, they could draw your blood and in three days tell you these particular 27 percent are going to do PTSD?
Yeah. And then you identify them and then you put them in supporting roles and you don't put them on front line.
And then you identify them and then you put them in supporting roles and you don't put them on front line.
You still allow the people to serve, but you don't put them in a position when you know that they have a predisposition for an ailment.
Yeah, that is that is amazing. Like military aside, just in general, being making sure it's almost like you're.
Yeah, just in general. You know, imagine the LA police department being able to identify, you know,
I know everybody's on race right now,
but how about debilitating stress, anxiety,
you know, stress disorders.
It'd be critical because if all of a sudden you have,
and they do have a very large police department,
if you found out which 30% are the ones that are snapping, it's time to put them behind the desk.
Yeah.
You know, allow people to serve, but just don't put predisposed people for violence in situations where it affects innocent people.
Yeah.
So that's really where our DAO is. I'm setting it up where it's an LLC for tax purposes
in Wyoming. For operational, it's an LLP in Ukraine. So it is registered in Ukraine as an
LLP. That way I can legally do it as a DAO. Ukraine is a very crypto-friendly country.
Once we do a launch, what will happen is it'll be disclosed.
The launch portion of the funds will be disclosed as to how much the clinic is going to cost, how much.
I have two physicians, nurses, which each individual treatment will be done in what order of priority.
And then once the ball starts going in three months, you have your first Dow voting
and you can update all your investors. Because that's another problem I saw in a lot of these
DSI projects is I don't want to call them scams, but
they don't show where the funds are.
Everybody talks about transparency, but I don't see any transparent, uh, D site projects.
You're not wrong.
You're absolutely not wrong.
Um, and I, you know, so this, again, this is episode six, this second season has been very critical on its or at least very candid on its
perception of where the space is where the space needs to be and i appreciate it i think we've had
very high caliber guests yourself included has kept the bar quite high um in what we're looking
at and yeah we need to have more real conversations about what it what it is to be a d-side dow what is to be a dow in
general um and what are some of the i like to use the word trial i like to use the term trials and
tribulations which is probably appropriate now because you're a lawyer um in actually running
yeah so let's let's touch upon that because you came from a classical series of entities, autism schools, you know, mental health institutions, and you see value in the DAO.
And I always have to ask the question, even though I operate in the DCI, I'm quite skeptical around DAOs.
I think that I have yet to see a use case where something could be accomplished with a DAO better than not.
And so it always, I'm always interested to understand the builder's perspective into why make it a DAO better than not. And so it always, I'm always interested
to understand the builder's perspective
into why make it a DAO and why not just have it be
a centralized entity that services people
that has public interest at heart.
Oh, I can tell you the easy answer is this fundraising.
If I do not have it as a DAO, you have to comply with the Securities and Exchange
Commission. And what I'm trying to raise is under $5 million, which means it's in between what's
called a 504 and a 505 Reg D offering. It makes it very difficult to be legally compliant because if you want to do it right and not the Twitter
scam you really need about a hundred forty thousand dollars right out the
gate just to be legally compliant after you've spent that one hundred forty
thousand dollars you still have to continue you still have to do your
quarterly filings you still have to have your accountants your securities
attorney and if you're in different countries still have to have your accountants, your securities attorney. And if
you're in different countries, you have to comply with each individual country. So in my case, I
would have to comply with the United States and comply with Ukraine. And there's no benefit
whatsoever, other than how you raise the funds. And then you run into the issue of is now that you've spent all this
money and you're in compliance, what exchange do you use? Do you use BNB? No. Which BNB?
Because they've done the Mitsubishi setup where there's a BNB in every country and it represents
itself and it's its own legal entity.
It isolates it for legal protection, but it makes it difficult because if you do a token offering on, let's say, New York BNB,
technically no other countries would be allowed to buy or sell it unless it's in compliance with that individual
country. I see. So I personally don't want to have an SEC violation. I know Trump is a very pro
do what you want. Apparently he's pardoning crypto criminals left and right, good for him. I don't imagine Sam Bakeman is going to too far off because he's already done the three others.
But from my perspective and the fact that I don't have tens of millions of dollars to protect myself from the SEC like XRP had to do,
I'd rather be in compliance in the beginning. don't have tens of millions of dollars to protect myself from the SEC like XRP had to do,
I'd rather be in compliance in the beginning. And for me to do that, I have to identify how can I raise the capital, how much capital is needed first. And I know for a fact that the capital
I need is about 3.5 to do to clinic, the doctors, the research, the studies, publishing, publishing is not cheap, you know, in any case, so I know what the
budget is, then you do the legal entity based on the budget, and what it is likely to raise capital.
And so that what that's what brought me to the decide world is I was seeing people.
And I'm just trying to think of a nice political way of
saying it. I saw pump science, which is not science. It's on any level. I'm surprised PETA is for them to doing what they're doing.
I see how much money they raised.
I saw on bio, you know, how much money was raised for various different projects that weren't very well written. You're talking about two to three pages of disclosures where mine's 47.
disclosures where mine's 47. You know, it's, you're seeing people raise anywhere from two to
$5 million. I'm not going to say garbage, because that's an objective, or, you know, that's,
that's very subjective, but essentially garbage. So I was hoping a real project would gain sight.
You know, and the difficult part is it's just not a sexy field.
And I am aware of that.
You know, like I see you, me, DeCentral, and one other listener.
And I'm thankful that the person's there.
I will answer any and every question a person asks me.
But I just know it's not a sexy field where if I had, you know, six mice dressed up as Marvel Avengers, you know, you could raise $3 million to do a live stream.
My God, it's just embarrassing.
It really is.
But I will say this i think this is the first time
in the four years that i've been in this space where
i like the first thing that comes to mind is you need to write a manifesto
like i think you truly need to write a manifesto of what are like as a use case right or even as
a test case like what are the considerations when looking to build out a
DAO in general, but also in the DSI space?
Because to your point, it is much more seed.
It is much more grounded in concrete application, which is usually inherently less speculative.
And so it doesn't attract.
So there's almost like this dichotomy that exists where science will never fit the Web3 narrative.
Now, DSi, I will say this, DSi is not synonymous with Web3.
It leverages Web3 or tries to leverage Web3 where applicable.
But by virtue of that.
How does it even mean corally?
Because just because somebody stores data on blockchain, how does that, does just automatically make you a web three it does
not and i was actually going to come to that point to you as one of my follow-up questions but but
before i get to that exactly that right like this this kind of very salient questioning in terms of
what does it mean to what is your entity looking to be if you can be a dow which means you know
you're a place for multiple parties to come in. That is less, maybe potentially less hierarchical than otherwise.
That doesn't necessarily make you a Web3 entity, right?
Like you can have these, there are DAO, quote unquote DAO as in, or maybe not DAO, but there are community led communal initiatives that have nothing to do with the tech stack underpinning it.
And that are somewhat successful or very successful or not successful and so like what are you looking to be um and and
i truly mean this james from especially from the design world perspective like getting a written
down manifesto of your thought process in building out spec truth now and the considerations that are
going into this this would be extremely valuable to people coming into the space and looking to understand one, who is building
what, but also how are people actually building towards success in this venture, in this industry?
Because that's something that we also don't have is, you know, a structured way to go
about this.
Everything is still somewhat of a grand experiment and it changes depending on
what modality of decide or what modality of science you're trying to tackle.
Um, it's fantastic.
Yeah, I agree with you, but I, I, I hate sounding like Jordan Peterson, but for,
for example, what, when I say web three or web two, what do you think of?
So that is, that is very, that is a very good point for me.
The crux of web three is ownership, right?
A way with, by a means by which to own some asset that I traditionally may not
have been ownable, right.
Or had, you know, much more hurdles to get to owns from the financial space, not needing
to be an accredited investor to get access to high yield returning vehicles in the scientific
realm, being able to own different intangible assets that previously were not either capturable
or accreditable or these kinds of things, or in the patient perspective, like owning
your own data, having infrastructure,
data management infrastructure in such a way
that you own your assets and you permission,
you have the sole keys to permission access to it.
And so it really depends.
Yeah, my thing is, is when I hear
Web3 versus Web2, decentralization comes to my mind more than anything
fair so when I think of web 2 I think of Google I think of a legacy company you
know I can walk into the headquarters of Microsoft and, you know, wherever their CEO is and they have a mailing address, a legal address.
And it's a very it's a traditional business that just happens to also be online.
To me, decentralized on the Web 3 is truly what it means your accountants in france your legal correspondence and you know
wyoming for tax purposes you know and it's truly decentralized and then it also goes into the
people using it which i agree 100 with you on fractional ownership you know so so when we do launch you are going to own a piece of the nft which will entitle you
to a percentage of our profits on overall and then also it gives governance in the sense that
um and this is going to go back to why you're asking on the dow and the governance part
i think the reason i want to do the governance is is it keeps the business from being hijacked from venture capitalists in a sense.
I know firsthand of a business that received money in Dubai.
Everything was going well.
He actually got the minimum viable product up and running they were going to launch
it and then it got shelled by the vcs and he got outvoted and it was just done his dreams gone
um because the the problem was they made more money by the problem continuing and not by actually
solving the problem yes so when i see certain pharmacology companies um announced you know
like we're putting 60 million we're putting in 600 million into you know various different projects
um people have to be careful and so i'm basically preemptively protecting the company from that kind of hijacking by making it a DAO.
So if all of a sudden Pfizer comes in and they buy everything, they buy all $5 million worth, it's still a DAO that still has to go through the purpose.
has to go through the purpose, the team determines what is being voted on.
The team determines what is being voted on.
So it's not like Pfizer can go to the team and say, we don't want you to cure PTSD.
All they can do is vote on what is votable.
And so the team would go through, well, do you want psilocybin?
Do you want Ibogaine or do you want this?
And it's like, we don't want any of it.
That's not the choice.
There is no letter d on on the
the voting on a governance um so that's one of the reasons why i'm highly inclined to keep it in the
dow perspective i like that to me it keeps it honest and and the goal is still moving forward
i very much like that and that's what I mean by the type of cases
that need to be chronicled
so that people understand what are the pros and cons.
Because that is a very salient pro,
especially in our space where there needs,
more often than not,
there needs to be large capital injection.
And I think any of the, every entity,
at least biomedically facing entity that I know of is looking to work with or at some point is open
to working with some of these larger entities right these more traditionally legacy entities
that comes with its own um catch-22s built into them and i think that to to your point you know
if you haven't set the foundation correct then you're just as liable
to be captured either by regulatory or by financial or financially by some of these entities where you
end up coming full circle into back into you you become a legacy entity effectively right and if
you're not positioned well then then then you can't hedge against that. And so again, like, I don't know,
my big takeaway here, James,
is I think we need to definitely study,
as you progress,
and I highly, highly, highly encourage people
who are listening to this after
and to the team who will be splitting out
some of these soundbites
to really hone in on some of these key factors,
because this is a conversation
that we don't have enough in this space
and is extremely important, especially for those that are going to
be successful and are going to be faced with, Hey, now somebody is willing to
throw a lot of money at you because you've done the test case.
You've proved out the proof of concept.
And now there are people who are biting.
How do you actually go about that in such a way as to keep the same values
that you started off with
and not, for lack of a better word,
fuck over the community that has helped you get this far.
Yeah, and that on exactly your point,
I see two things that come to my mind.
One, the launch pads that fuck their people.
I gotta tell you, you know, like, so my Bitcoin, when I bought it, I bought it at 27,000.
So even though it's going down to the mid 80s, I'm still happy.
Yeah.
But about a year ago, I tore off about 20% of mine because I was expecting this alt pump that was supposed to happen once it got to like 106,000.
So I tore off about 20% of my Bitcoin holdings and I put it into AI agents and D-Sci.
Holy shit.
Yes.
I mean, from a fundamental perspective, I do not know why my bio went down.
I don't know why my cerebrum went down.
You know, my virtuals.
You know, so if you have pumped up fun going parabolic, why wasn't virtualss which is a very similar thing except using ai agents which is
apparently supposed to be the future with ai frameworks um
then on the other side of it you know so so you definitely have dev teams just dumping constantly on people um i can't tell you why a company that on its face i think looks great
like dynex they've offered to partner with me where they're going to do the big data using
quantum language modeling everything sounds great but then you look at the charts and and it's just
everything sounds great but then you look at the charts and and it's just where are these sellers
coming from other than the developers um well so this is the thing right with and you know what i
i francesca i know you're up here and for context francesca is is somebody who is active in the
dsai space she's been around for a while she is she is big she's from the oris high ecosystem but
she is more than just that. She's a fantastic person.
And I think I know for a fact that this particular topic is of interest to her.
And so I'm glad that she is here and I'll let you guys speak.
But to that point, when you're raising capital off of token sales, you have to dump the token to realize those profits.
So there's almost this inherent like yeah you know
you're helping us you're helping us raise by buying these assets but we have to kind of draw
down on them because the only way for us to actually buy and transact in the real world in
the meat space is by liquidating those things well the only reason i would disagree with that
is i would say the auction setup i i think is the one is the best route. The only reason I
keep on bringing a bio is because I really liked how they said, you know, like, okay, our minimum
is, you know, 750,000, our maximum is whatever 2 million. So in theory, if you get that $750,000, you should be able to do the project where you shouldn't dump any of your treasury tokens.
And your dev team shouldn't have theirs locked up for a minimum of six months to 18 months.
And you let the free market decide its token valuation.
Or personally, if I was going to do it i would raise probably 20 more
so let's just say i needed three and a half million i would raise 4.2 and i would tell
everybody 20 of that is going to be in liquid treasury for um keeping things stabilized yep
it's not illegal it's not illegal it's not wrong you're disclosing it exactly you know you
just keep it stabilized for everybody um because you do have like i invested in spined up i i like
the idea i like the project i like the fundamentals i like everything about it but like all things
it's gonna open it's gonna go up and then it's gonna tank 70
and then i hope in three years from now i'll 10 exit on that and that's also the so you talk about
exactly that right so i completely agree with you i think the the the the gem here is transparency
to your point and to your earlier point there's people are like there's just a lack of transparency
ironically in this space and has
nothing to do with the infrastructure has really to do with the business dynamics and then there
just needs to be a lot more and i think part of it and i don't necessarily think it's all malicious
i think there are a lot of people who have started a lot of things that do not have the business
acumen or don't have the the the true understanding of what they are doing and they're kind of making it up as they go
and so that is going to have a a significant amount of stumbles and fumbles that sometimes
will look like malicious intent now i know firsthand that there is has been malicious
intent in other applications throughout this space so not to discredit that either um but yes
we we need we need more transparency there and and again and i
say this at the end of each spaces is this is the conversation this is why we have these conversations
to allow people to learn and see who is developing behind these projects what is their ethos what is
their mindset and how are they going about the development and i think that you speak very highly
to the fact that spec truth doubt whatever it is to become and however it manifests in the real world at the very least, there is
somebody with a very smart head, a solid head on their shoulders in terms of
understanding some of the pitfalls that they're not pitfalls, but how to properly
architect what this could be so that it can get to where it needs to be.
And it's a very doable. be and it's very doable yeah it is very does your friend have any questions she wants to ask or no
well so yes i was gonna get that so francesca please i know we kind of monopolized it a bit
but but please unmute yourself and ask james any and all the questions that you have
she may have just been listening or stepped away yeah so i mean
to your to your point sorry i'm uh multitasking um we are
what was the question because i was listening with one ear and and and doing a rsi meeting
it wasn't questions if you you had questions, Francesca,
if you wanted to chime in here at any point.
Yeah, I was, I actually,
the reason why I logged in
is because I saw the post
and I was like, oh, interesting.
Another project because I'm aware of Elada
and what they're doing,
you know, the open source EEG.
And I wanted to know a little bit more
what was the take,
but then I had a conflicting call
around that time and you know my experience with PTSD and it's very different with veterans because
I think it's a little bit more hardwired but is that many times both the diagnostic and the treatments get very much blurry.
And a lot of people in general, and I've seen from my experience also veterans,
struggle with pharmaceuticals because in they they cause a lot of side
effects and so getting you know someone that is struggling with ptsd which is usually comes with
depression anxiety panic attacks and and so on and so on they um they have uh um they really They really have a hard time taking this treatment for a really long time.
So the holistic approach has helped what I've seen a lot to support these therapies.
For holistic support, I mean practices like yoga like you know breathing meditation
and but a lot of times it's very difficult for them to to tap into the this this um these
alternatives from from uh from the start what has been your experience kind of uh you know and
your hands-on experiences so far and how is this project that
you're building different or or bringing kind of like a breath of fresh air perhaps
with with the novel therapies and what what kind of novel therapies are you are you looking to
explore with this group that's a great question. Actually, I've talked to Mark
from Cerebrum, where they're doing the earbuds with the EGs. I actually am going to be talking
to Kyle, I believe tomorrow. Awesome. With Alara. I love both projects. So I'm not going to,
when I see a project that's doing well, I will speak very highly of it. And then when I see a project that I think is shit, I definitely will tell you when I think it's shit.
They're more, I would say it is a scientific,
how do you say it?
It's instruments really,
where I'm focusing on the therapy side.
So I will gladly use whatever is the best product
for the soldiers to have PTSD outcomes,
regardless of the source.
So in other words, if it was Axon Dow's Cure Ring,
a lot of EEG that they're now building for like $500.
They're doing amazing stuff, both groups.
Where I'm doing it is I'm taking PTSD
and I'm cutting it basically into two parts.
One part is behavioral.
And behavioral is 66% of all people who suffer from PTSD are female.
And it is more related to personal trauma, meaning, you know, 10 years of an abusive relationship,
child dying, postpartum depression. There's a there's a lot of elements to to why they
represent two thirds of PTSD on the remaining portion that I'm focusing on,
because it's such a wide spectrum, you really need to focus on one thing. I'm focusing on the
soldiers in the Ukraine area. And in that area, I agree 100% with you. And the behavioral therapy
is going to have minimal effect for somebody that's having chronic PTSD.
Now, that's not saying they won't have an effect.
It's just it'll have a different effect.
So what we're doing is we're creating an agentic AI that'll do, first off, the diagnostic.
It'll identify whether it's behavioral.
Number one, if PTSD exists.
Two, is it behavioral?
Three, is it behavioral? Three, is it biological? Assuming that it is behavioral,
then what we're going to do is have an agentic AI go through the cognitive behavioral therapy.
And if you look at Wysa, W-Y-S-A, it's a company out of America. They have an agentic AI that's
in the mid-80s for cognitive behavioral therapy having a positive
outcome. And everything is showing that it can replace human interaction on a therapy.
And now on that 15 to 16% that don't receive benefit from, what we'll do is we'll refer them
to an actual physical therapist. By doing that, we're maximizing the benefit that the physical
therapist is going to have because they're being overwhelmed. There's so many people that need the
therapy. We can actually funnel it where they're going to have the most benefit with the people
that have the highest probability of success. Second, and I was talking to a gentleman by the name of Sam today, and he's with MUDU, M-U-H-D-U-O.
And what they do is biomarkers.
And so what we're going to do is most likely their team, 99%, unless, you know, somebody comes out better, but I don't see it happening.
What we'll do is do the biomarkers where we know exactly where the person is right at that minute, biological wise.
Bio, vitals, heavy metals, you name it. We need to have a picture of the person that's about to get biological treatment.
Then they need to go through a detox.
Then they need to go through a detox.
The reason you want to go through a detox is because you need to maximize the benefits and eliminate your outliers.
Because if one person has heavy metals like mercury and another person has a parasite, when you introduce a foreign substance like Ibogaine, it could alter the outcomes.
So what we have to do is we have to bring people to their highest physical state,
which typically can be anywhere from 48 to 72 hours.
I know Save the Warriors has a 72-hour decompression before people go into certain treatments,
and I think their protocol is amazing and will probably mimic it
just because they're showing promise.
Once somebody goes through that way,
identifying if they have heavy metals,
you put them in through chelation therapy.
If they have parasites,
obviously you give them medicine for that
and you address everybody to get there
to their best physical state.
Once we do that, you then take another
biomarker because now you have before physical treatment, after physical treatment, and now
you're going to try and do the PTSD treatment. On the PTSD treatment, there's actually a lot
of different avenues that we want to explore. One is Ibogaine.
It's very high.
It's recommended.
They're currently doing it in Mexico with great results.
The obvious downsides to Ibogaine is there's 2% of heart arrhythmia that can be caused.
So a person has to be monitored for at least the first 12 hours by a cardiologist and be aware that there is a 2%
chance that somebody could have a heart issue. We also want to explore psilocybin.
We originally were going to be doing it in the United States, but there's been absolutely no
changes to the federal laws on psilocybin being a Schedule I drug. And so none of the doctors I'm working with
want to risk their hard-earned medical degrees
over experiments when we could do them in Ukraine
and have a relationship with the government
where they'll allow it.
We're in the process of working through that now.
In addition to that, we have what's called SGV blockers.
That goes through the vagus nerve. And there's an interesting
thing out of Spain where they are doing TMS, which is a magnetic pulse into the brain,
that they're doing it for depression. And we're curious if that could actually
be repurposed to do PTSD because there is a huge overlap. Depression and PTSD has an 86%
overlap. So there's a lot of commonalities where one cure could also help the other person.
And that's just a start. We also want to explore certain peptides.
There's a lot of avenues that we want to explore. And the idea is to not have it where people are hooked on pharmaceuticals
for the rest of their life.
Wow, it sounds like I don't think any veterans has ever received
any sort of care like that.
My father has PTSD.
He's been in the VA system practically almost by my whole life.
I can countless, countless, countless veterans.
I've never met anybody that not only received any respect, let alone any treatments, because it's still a stigma.
You know, it's people think that it's a sign of weakness, not realizing what PTSD is.
You know, it's fright or flight and you're exposed to so much trauma that your nervous
system gets permanently locked into that.
So rather than being able to deescalate, you are permanently in the flight or fright.
So if you're going through a grocery store, having a meal, you're at McDonald's and somebody
drops something on the ground and it makes an explosion sound, you and I, we're fine. Our
nervous systems, we're good. We hear it, we look at it. If we were in a heightened state, meaning our body is exactly the same as going through artillery shells and zero line in Ukraine, it would be a completely different response.
And so people look at it as a sign of weakness when it's not.
It's biological.
It's something that has happened to that person's nervous system that needs to be reset.
that has happened to that person's nervous system that needs to be reset.
And if we can find that solution and we can get it into the mid-80s, low-90s,
hell, I would love 100%, but it's medicine, so that's not possible.
But if we could get it into the high-80s, low-90s, one stop, one cure moment,
it would be amazing.
100%. I wanted to comment a couple of things. You mentioned physical therapy. I would assume
it's psychosomatic, so you work on the muscle tissues?
Honestly, we haven't gotten to that point.
That has not come up in any of our discussions yet. I would love to learn more if you feel that it shows any long-term benefit.
Yeah, I'll send you some stuff.
And then the other thing is that a comment that is, I believe,
a study currently happening in Stanford, don't quote me,
but I can get information about that.
It is using TMS for PTSD and they are doing specific studies on certain cases that haven't had a lot of results with pharmaceuticals.
I'm aware of the study. I find it interesting. It's good
where I find most of the studies that are coming out of the United States, and I love Aleta. I
love all the stories they post. It keeps me informed. What I find depressing is when you
see that the study group is 11 people, 9 people, 29 people. And even in the Stanford study, if I remember it
correctly on the TMS, there's a lot of outside variables. There's outliers that are affecting it
where the opportunity we have with Spectruth and being in Ukraine with zero lines soldiers coming back is everybody wants to know
a solution. So, you know, we're having people that easily will volunteer because we're not
going to be doing placebos. We're not going to be doing a placebo group and a treatment group.
I personally find that unethical to the soldiers. So when we do a group,
if we can work with a group out of Spain that does TMS,
if we could do a hundred people and then publish it,
I know there's some D side projects like Noble Blocks
and Research Hub where it's inexpensively allowed
where we can publish it for peer review, we certainly will.
But we also wanna be more in the traditional legacy group it for peer review. We certainly will. But we also want to be more in the traditional legacy group also for peer review.
We don't want to just be that fringe group that nobody's ever heard of.
We actually want to have real studies done and join with groups like King's College,
Stanford, Yale.
We want to become legacy, but also utilize the benefits of decentralization.
Awesome. Great comments.
The other thing that I wanted to say is pharmaceutical mushrooms is a thing.
A lot of times it's much easier to utilize pharmaceutical mushrooms
and that makes usually practitioners feel safer to utilize.
But I understand your motive of being outside the U.S.
because there is so much less regulation.
The one thing I don't know if you took into consideration
is that some people react to these psychoactive drugs.
And if there is a genetic predisposition, it could offset psychosis?
It's an absolutely great question.
I see that being asked by multiple people.
I even think a PsyDOW did something either last week or something along those lines.
I spoke to PsyDOW about this and I think it's a big problem
and it could be easily fixed by also having a genetic test.
And I think that we should collect more of that data because it does not always, you know,
two plus two is not always four in this case.
It doesn't always offset these kind of experiences, but it could.
And I've seen people not coming back from taking this type of drugs and then thinking of curing something and then having a much larger issue.
I agree with that.
And that's also it sort of goes along with what I was talking about with the biomarkers.
So we're saying the same thing.
We're just maybe talking about it from a different angle.
about it from a different angle. The reason we want to do the biomarkers when somebody walks
into the door when they're basically acknowledged as having it is so we know where they are. You
know, parasites, yeast infection, you know, heavy metals. Are they dehydrated? You know,
do we need to get them on like Celtic salt and water to start helping their hormonal balances. Where exactly are they on the
physical? Get them to the physical optimum. You know, obviously, you know, we're not looking for
optimum BMI where, you know, it may take 10 years to get them there, but we're talking about gut
health, brain health, parasites, things of that nature that can be fixed within, say, 48 to 72 hours.
And then you take another biomarker and then you actually go through treatment protocol. So if we
did do psilocybin, we have to get approved by the Ukraine Ministry of Health for that. But
Ibogaine pretty much is already approved. If we did do the psilocybin, yes,
that would be wonderful to find out what the biomarkers are
to know when somebody has a psychotic break.
Awesome.
And one thing, last thing is,
and I love that you're taking all this progression
sounds like, you know,
it's very well organized and thought out.
Sugar.
So nutrition really helps.
Having a well-balanced nutrition really helps being able to create
the right environment for behavioral therapy
and all sorts of different, yeah, in general interventions.
It seems like sugar creates a really unstable environment
with people that have this kind of issues
and mood swings and so on and so on.
So I will definitely look to create a balanced diet,
a nutritional diet for each person,
perhaps utilizing AI and webbing all these biomarkers
would allow you to really pinpoint also the diets
that each person, personalized diets that each person needs to take.
I think that's a great point.
I can say, I don't know if you heard the beginning, but so I have an experience of running and operating clinics for autism.
And I can definitely agree that sugar plays a huge part on gut health, hormones, attention span.
hormones, attention span. It's just, yeah, the sugar is definitely pouring gasoline on a fire
when you're dealing with mental health issues. 100%. Thank you so much for, you know, taking
the time and in general, you know, dedicating your life probably also because you can understand firsthand
what people go through and taking this to, you know, on a larger scale to help others.
That's great.
And this is a great way to utilize DSi and Web3 and innovative technology.
Yeah, for the better environment of everyone.
No, and thank you for your questions.
And I know Jelani has my email, so feel free,
or even on my Telegram, it's just at Spectruth,
or here, Spectruth AI.
I'll be happy to answer all questions.
I'm open-minded to alternative therapies and adding
things to the list because I realize that obviously, you know, there's a reason why they
have certain remedies in China, certain remedies in Russia, certain remedies in, you know, Mexico.
There's not one fix for everybody. And with the biomarkers and the way technology is advancing,
I'm hoping we can identify which will work for which person.
I think this, I mean, we've definitely gone over on time,
but this is one of the few times.
No, no, no, no, no, no, no, no, no, no, no.
This is one of the few times where I think it was definitely
really worthwhile to have this open-ended discussion.
Francesca, thank you for coming up and asking and pulling in really, really insightful points.
James, one thing that I want to say, I mean, you've expounded on not only your knowledge base from a scientific perspective or from an application perspective, a therapeutic perspective, but also a knowledge base from a legal perspective, from a business acumen.
But I do want to also touch upon the face that you have a lot of care in the way that
you articulate the mission.
And I think that is one of those intangible things that is very, very powerful, especially
when you're looking to approach this as a Tao, as a community collective, as a community
facing thing
the way that you speak about it is almost enchanting and so i want to give you another
set of kudos for that there that kind of of intimacy that you bring into to talking about
something that is profoundly affects people on a number of different levels and i have people in
my family who have pts. I have people who I deal
with now have PTSD. I've started my own therapy journey to just try to understand what has,
what exists under all of the, you know, the, not the facade, but what is front facing.
So I think this is fantastic. I love how you approach this. I definitely want to put you in
contact. I'm glad that Francesca here. I'm glad you guys are in contact. There are a number of
other people in the space who I think are building things that may definitely synergize with you. And I'm going to be reaching out offline once we're done with this to talk about those kind of things. But I guess just to cap it all off, I'll kind of give you the floor to say to allow people to learn where they can come and learn more, how they can help participate and just give you the last, the final words to the space.
Well, thank you very much.
I love the kind words.
It's being in a country where 99% of people don't speak English.
I don't get to have these conversations very often,
but to the same depth or eloquence.
It is a very important subject matter just in the fact that it is global and
it is everywhere. Like you said, your friends, your family. I don't know anybody who isn't
affected by PTSD. And it's not just the Ukraine side. It's being on the American side growing up
on military bases. It does pass down from generation to generation. We've seen it in different studies.
If we can find the ultimate cure now, you know, find out what works, it's just important.
We can save so many people's mental health and try and help people just live life,
actually enjoy living life for the first time in their existence.
It's very vital that we do this.
As for following me, follow me on X.
Because we're traveling between Ukraine, Poland, and power outages and everything else, we update our X regularly.
That is probably the best way to do it.
Telegram, we update maybe every three, four weeks.
And then I'm always answering emails.
So I would say if anybody wants to reach out,
it would be here on X.
And I would love to collaborate with as many people
as necessary to get this project going.
Amazing.
Well, you've heard it here, folks.
We'll be releasing clips and short pieces that highlight all of this.
James, again, thank you so much for taking the time.
I know it's getting late where you are, but I really appreciate it.
Francesca, I appreciate you as well.
And for everybody who's going to be listening in afterwards,
thank you for taking the time to listen to what I have no doubt
is going to be an amazing project.
The space really is moving in the direction where it needs to go and it's just
make sure you find those gems and make sure you you put together a good rubric to evaluate which
projects are are have more substance than not so with that guys um thank you again we'll be back
in two weeks with another episode um but definitely follow and reach out to those here that you've heard speak.
James, Francesca, thanks, guys.
Have a great rest of your day.
You too. Thank you.
Take it easy. Bye-bye.
Host
DeSciWorld
from
DeSciWorld
